author_facet Thole, Theresa M.
Toedling, Joern
Sprüssel, Annika
Pfeil, Sebastian
Savelyeva, Larissa
Capper, David
Messerschmidt, Clemens
Beule, Dieter
Groeneveld‐Krentz, Stefanie
Eckert, Cornelia
Gambara, Guido
Henssen, Anton G.
Finkler, Sabine
Schulte, Johannes H.
Sieber, Anja
Bluethgen, Nils
Regenbrecht, Christian R. A.
Künkele, Annette
Lodrini, Marco
Eggert, Angelika
Deubzer, Hedwig E.
Thole, Theresa M.
Toedling, Joern
Sprüssel, Annika
Pfeil, Sebastian
Savelyeva, Larissa
Capper, David
Messerschmidt, Clemens
Beule, Dieter
Groeneveld‐Krentz, Stefanie
Eckert, Cornelia
Gambara, Guido
Henssen, Anton G.
Finkler, Sabine
Schulte, Johannes H.
Sieber, Anja
Bluethgen, Nils
Regenbrecht, Christian R. A.
Künkele, Annette
Lodrini, Marco
Eggert, Angelika
Deubzer, Hedwig E.
author Thole, Theresa M.
Toedling, Joern
Sprüssel, Annika
Pfeil, Sebastian
Savelyeva, Larissa
Capper, David
Messerschmidt, Clemens
Beule, Dieter
Groeneveld‐Krentz, Stefanie
Eckert, Cornelia
Gambara, Guido
Henssen, Anton G.
Finkler, Sabine
Schulte, Johannes H.
Sieber, Anja
Bluethgen, Nils
Regenbrecht, Christian R. A.
Künkele, Annette
Lodrini, Marco
Eggert, Angelika
Deubzer, Hedwig E.
spellingShingle Thole, Theresa M.
Toedling, Joern
Sprüssel, Annika
Pfeil, Sebastian
Savelyeva, Larissa
Capper, David
Messerschmidt, Clemens
Beule, Dieter
Groeneveld‐Krentz, Stefanie
Eckert, Cornelia
Gambara, Guido
Henssen, Anton G.
Finkler, Sabine
Schulte, Johannes H.
Sieber, Anja
Bluethgen, Nils
Regenbrecht, Christian R. A.
Künkele, Annette
Lodrini, Marco
Eggert, Angelika
Deubzer, Hedwig E.
International Journal of Cancer
Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
Cancer Research
Oncology
author_sort thole, theresa m.
spelling Thole, Theresa M. Toedling, Joern Sprüssel, Annika Pfeil, Sebastian Savelyeva, Larissa Capper, David Messerschmidt, Clemens Beule, Dieter Groeneveld‐Krentz, Stefanie Eckert, Cornelia Gambara, Guido Henssen, Anton G. Finkler, Sabine Schulte, Johannes H. Sieber, Anja Bluethgen, Nils Regenbrecht, Christian R. A. Künkele, Annette Lodrini, Marco Eggert, Angelika Deubzer, Hedwig E. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.32572 <jats:p>Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC‐NB1, from a bone marrow metastasis from a patient diagnosed with <jats:italic>MYCN‐</jats:italic>amplified neuroblastoma and performed whole‐exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC‐NB1 harbors a <jats:italic>MYCN</jats:italic> amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single‐nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC‐NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system.</jats:p> Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model International Journal of Cancer
doi_str_mv 10.1002/ijc.32572
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzI1NzI
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzI1NzI
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
issn 0020-7136
1097-0215
issn_str_mv 0020-7136
1097-0215
language English
mega_collection Wiley (CrossRef)
match_str thole2020reflectionofneuroblastomaintratumorheterogeneityinthenewohcnb1diseasemodel
publishDateSort 2020
publisher Wiley
recordtype ai
record_format ai
series International Journal of Cancer
source_id 49
title Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_unstemmed Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_full Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_fullStr Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_full_unstemmed Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_short Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_sort reflection of neuroblastoma intratumor heterogeneity in the new ohc‐nb1 disease model
topic Cancer Research
Oncology
url http://dx.doi.org/10.1002/ijc.32572
publishDate 2020
physical 1031-1041
description <jats:p>Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC‐NB1, from a bone marrow metastasis from a patient diagnosed with <jats:italic>MYCN‐</jats:italic>amplified neuroblastoma and performed whole‐exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC‐NB1 harbors a <jats:italic>MYCN</jats:italic> amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single‐nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC‐NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system.</jats:p>
container_issue 4
container_start_page 1031
container_title International Journal of Cancer
container_volume 146
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792342795247157248
geogr_code not assigned
last_indexed 2024-03-01T16:41:29.1Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Reflection+of+neuroblastoma+intratumor+heterogeneity+in+the+new+OHC%E2%80%90NB1+disease+model&rft.date=2020-02-15&genre=article&issn=1097-0215&volume=146&issue=4&spage=1031&epage=1041&pages=1031-1041&jtitle=International+Journal+of+Cancer&atitle=Reflection+of+neuroblastoma+intratumor+heterogeneity+in+the+new+OHC%E2%80%90NB1+disease+model&aulast=Deubzer&aufirst=Hedwig+E.&rft_id=info%3Adoi%2F10.1002%2Fijc.32572&rft.language%5B0%5D=eng
SOLR
_version_ 1792342795247157248
author Thole, Theresa M., Toedling, Joern, Sprüssel, Annika, Pfeil, Sebastian, Savelyeva, Larissa, Capper, David, Messerschmidt, Clemens, Beule, Dieter, Groeneveld‐Krentz, Stefanie, Eckert, Cornelia, Gambara, Guido, Henssen, Anton G., Finkler, Sabine, Schulte, Johannes H., Sieber, Anja, Bluethgen, Nils, Regenbrecht, Christian R. A., Künkele, Annette, Lodrini, Marco, Eggert, Angelika, Deubzer, Hedwig E.
author_facet Thole, Theresa M., Toedling, Joern, Sprüssel, Annika, Pfeil, Sebastian, Savelyeva, Larissa, Capper, David, Messerschmidt, Clemens, Beule, Dieter, Groeneveld‐Krentz, Stefanie, Eckert, Cornelia, Gambara, Guido, Henssen, Anton G., Finkler, Sabine, Schulte, Johannes H., Sieber, Anja, Bluethgen, Nils, Regenbrecht, Christian R. A., Künkele, Annette, Lodrini, Marco, Eggert, Angelika, Deubzer, Hedwig E., Thole, Theresa M., Toedling, Joern, Sprüssel, Annika, Pfeil, Sebastian, Savelyeva, Larissa, Capper, David, Messerschmidt, Clemens, Beule, Dieter, Groeneveld‐Krentz, Stefanie, Eckert, Cornelia, Gambara, Guido, Henssen, Anton G., Finkler, Sabine, Schulte, Johannes H., Sieber, Anja, Bluethgen, Nils, Regenbrecht, Christian R. A., Künkele, Annette, Lodrini, Marco, Eggert, Angelika, Deubzer, Hedwig E.
author_sort thole, theresa m.
container_issue 4
container_start_page 1031
container_title International Journal of Cancer
container_volume 146
description <jats:p>Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC‐NB1, from a bone marrow metastasis from a patient diagnosed with <jats:italic>MYCN‐</jats:italic>amplified neuroblastoma and performed whole‐exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC‐NB1 harbors a <jats:italic>MYCN</jats:italic> amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single‐nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC‐NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system.</jats:p>
doi_str_mv 10.1002/ijc.32572
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzI1NzI
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 0020-7136, 1097-0215
issn_str_mv 0020-7136, 1097-0215
language English
last_indexed 2024-03-01T16:41:29.1Z
match_str thole2020reflectionofneuroblastomaintratumorheterogeneityinthenewohcnb1diseasemodel
mega_collection Wiley (CrossRef)
physical 1031-1041
publishDate 2020
publishDateSort 2020
publisher Wiley
record_format ai
recordtype ai
series International Journal of Cancer
source_id 49
spelling Thole, Theresa M. Toedling, Joern Sprüssel, Annika Pfeil, Sebastian Savelyeva, Larissa Capper, David Messerschmidt, Clemens Beule, Dieter Groeneveld‐Krentz, Stefanie Eckert, Cornelia Gambara, Guido Henssen, Anton G. Finkler, Sabine Schulte, Johannes H. Sieber, Anja Bluethgen, Nils Regenbrecht, Christian R. A. Künkele, Annette Lodrini, Marco Eggert, Angelika Deubzer, Hedwig E. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.32572 <jats:p>Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC‐NB1, from a bone marrow metastasis from a patient diagnosed with <jats:italic>MYCN‐</jats:italic>amplified neuroblastoma and performed whole‐exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC‐NB1 harbors a <jats:italic>MYCN</jats:italic> amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single‐nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC‐NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system.</jats:p> Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model International Journal of Cancer
spellingShingle Thole, Theresa M., Toedling, Joern, Sprüssel, Annika, Pfeil, Sebastian, Savelyeva, Larissa, Capper, David, Messerschmidt, Clemens, Beule, Dieter, Groeneveld‐Krentz, Stefanie, Eckert, Cornelia, Gambara, Guido, Henssen, Anton G., Finkler, Sabine, Schulte, Johannes H., Sieber, Anja, Bluethgen, Nils, Regenbrecht, Christian R. A., Künkele, Annette, Lodrini, Marco, Eggert, Angelika, Deubzer, Hedwig E., International Journal of Cancer, Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model, Cancer Research, Oncology
title Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_full Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_fullStr Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_full_unstemmed Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_short Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
title_sort reflection of neuroblastoma intratumor heterogeneity in the new ohc‐nb1 disease model
title_unstemmed Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model
topic Cancer Research, Oncology
url http://dx.doi.org/10.1002/ijc.32572